Endothelial cell activation and proliferation modulate NKG2D activity by regulating MICA expression and shedding

Journal of Innate Immunity

Volumn 6, Issue 1, 2014, Pages 89-104

  Chauveau, Annabelle ^a   Tonnerre, Pierre ^a   Pabois, Angélique ^a   Gavlovsky, Pierre Jean ^a   Chatelais, Mathais ^a   Coupel, Stéphanie ^a   Charreau, Béatrice ^a  

^a INSERM   (France)

Author keywords

Cytokines; Endothelial cells; MICA; NKG2D; Signaling

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; JANUS KINASE; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; NATURAL KILLER CELL RECEPTOR NKG2D; TUMOR NECROSIS FACTOR ALPHA; HLA A ANTIGEN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; EFFECTOR CELL; ENDOTHELIUM CELL; ENZYME ACTIVITY; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURFACE PROPERTY; WOUND HEALING; CELL MEDIATED CYTOTOXICITY; CELL SURFACE; CONFOCAL MICROSCOPY; CYTOTOXICITY ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNOFLUORESCENCE; NORMAL HUMAN; PROTEIN GLYCOSYLATION; PROTEIN SYNTHESIS; SUPERNATANT; UPREGULATION; WESTERN BLOTTING;

CELL LINE; CELL PROLIFERATION; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERFERON-GAMMA; ISOANTIGENS; KILLER CELLS, NATURAL; MAP KINASE SIGNALING SYSTEM; NF-KAPPA B; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PROTEIN PROCESSING, POST-TRANSLATIONAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84893712488     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000351605     Document Type: Article

References (52)

1. Pober JS, Min W, Bradley JR: Mechanisms of endothelial dysfunction, injury, and death. Annu Rev Pathol 2009; 4: 71-95
2. Mantovani A, Bussolino F, Introna M: Cytokine regulation of endothelial cell function: From molecular level to the bedside. Immunol Today 1997; 18: 231-240
3. Dimmeler S, Haendeler J, Zeiher AM: Regulation of endothelial cell apoptosis in atherothrombosis. Curr Opin Lipidol 2002; 13: 531-536
4. Libby P, Pober JS: Chronic rejection. Immunity 2001; 14: 387-397
5. Choi J, Enis DR, Koh KP, Shiao SL, Pober JS: T lymphocyte-endothelial cell interactions. Annu Rev Immunol 2004; 22: 683-709
6. Pober JS, Tellides G: Participation of blood vessel cells in human adaptive immune responses. Trends Immunol 2012; 33: 49-57
7. Briscoe DM, Sayegh MH: A rendezvous before rejection: Where do T cells meet transplant antigens? Nat Med 2002; 8: 220-222
8. Pober J, Orosz CG, Rose ML, Savage CO: Can graft endothelial cells initiate a host anti-graft immune response? Transplantation 1996; 61: 343-349
9. Mason PM, Parham P: HLA class I region sequences, 1998. Tissue Antigens 1998; 51: 417-466
10. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T: Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA 1996; 93: 12445-12450
11. Zwirner NW, Fernandez-Vina MA, Stastny P: MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes. Immunogenetics 1998; 47: 139-148
12. Zwirner NW, Dole K, Stastny P: Differential surface expression of MICA by endothelial cells, fibroblasts, keratinocytes, and monocytes. Hum Immunol 1999; 60: 323-330
13. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T: Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999; 285: 727-729
14. Schrambach S, Ardizzone M, Leymarie V, Sibilia J, Bahram S: In vivo expression pattern of MICA and MICB and its relevance to autoimmunity and cancer. PLoS ONE 2007; 2:e518
15. Bahram S, Mizuki N, Inoko H, Spies T: Nucleotide sequence of the human MHC class I MICA gene. Immunogenetics 1996; 44: 80-81
16. Ogasawara K, Lanier LL: NKG2D in NK and T cell-mediated immunity. J Clin Immunol 2005; 25: 534-540
17. Bahram S, Inoko H, Shiina T, Radosavljevic M: MIC and other NKG2D ligands: From none to too many. Curr Opin Immunol 2005; 17: 505-509
18. Stephens HA: MICA and MICB genes: Can the enigma of their polymorphism be resolved? Trends Immunol 2001; 22: 378-385
19. Zwirner NW, Marcos CY, Mirbaha F, Zou Y, Stastny P: Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients. Hum Immunol 2000; 61: 917-924
20. Sumitran-Holgersson S, Wilczek HE, Holgersson J, Soderstrom K: Identification of the nonclassical HLA molecules, MICA, as targets for humoral immunity associated with irreversible rejection of kidney allografts. Transplantation 2002; 74: 268-277
21. Amezaga N, Crespo M, Lopez-Cobos M, Millan MA, Vinas O, Sole M, Oppenheimer F, Martorell J, Ercilla MG: Relevance of MICA antibodies in acute humoral rejection in renal transplant patients. Transpl Immunol 2006; 17: 39-42
22. Terasaki PI, Ozawa M, Castro R: Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant 2007; 7: 408-415
23. Hankey KG, Drachenberg CB, Papadimitriou JC, Klassen DK, Philosophe B, Bartlett ST, Groh V, Spies T, Mann DL: MIC expression in renal and pancreatic allografts. Transplantation 2002; 73: 304-306
24. Collins RW: Human MHC class I chain related (MIC) genes: Their biological function and relevance to disease and transplantation. Eur J Immunogenet 2004; 31: 105-114
25. Coupel S, Leboeuf F, Boulday G, Soulillou JP, Charreau B: RhoA activation mediates phosphatidylinositol 3-kinase-dependent proliferation of human vascular endothelial cells: An alloimmune mechanism of chronic allograft nephropathy. J Am Soc Nephrol 2004; 15: 2429-2439
26. Le Bas-Bernardet S, Coupel S, Chauveau A, Soulillou JP, Charreau B: Vascular endothelial cells evade apoptosis triggered by human leukocyte antigen-DR ligation mediated by allospecific antibodies. Transplantation 2004; 78: 1729-1739
27. Coupel S, Moreau A, Hamidou M, Horejsi V, Soulillou JP, Charreau B: Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation. Blood 2007; 109: 2806-2814
28. Allard M, Oger R, Vignard V, Percier JM, Fregni G, Perier A, Caignard A, Charreau B, Bernardeau K, Khammari A, Dreno B, Gervois N: Serum soluble HLA-E in melanoma: A new potential immune-related marker in cancer. PLoS One 2011; 6:e21118
29. Le Bas-Bernardet S, Hourmant M, Coupel S, Bignon JD, Soulillou JP, Charreau B: Non-HLA-Type endothelial cell reactive alloantibodies in pre-Transplant sera of kidney recipients trigger apoptosis. Am J Transplant 2003; 3: 167-177
30. Tonnerre P, Gerard N, Chatelais M, Poli C, Allard S, Cury S, Bressollette C, Cesbron-Gautier A, Charreau B: MICA variant promotes allosensitization after kidney transplantation. J Am Soc Nephrol 2013; 24: 954-966
31. Tieng V, Le Bouguenec C, du Merle L, Bertheau P, Desreumaux P, Janin A, Charron D, Toubert A: Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc Natl Acad Sci USA 2002; 99: 2977-2982
32. Allard M, Tonnerre P, Nedellec S, Oger R, Morice A, Guilloux Y, Houssaint E, Charreau B, Gervois N: HLA-E-restricted cross-recognition of allogeneic endothelial cells by CMVassociated CD8 T cells: A potential risk factor following transplantation. PLoS One 2012; 7:e50951
33. Devalliere J, Chatelais M, Fitau J, Gerard N, Hulin P, Velazquez L, Turner CE, Charreau B: LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets α-parvin to control cell adhesion and migration. FASEB J 2012; 6: 2592-606
34. Mizuki N, Ota M, Kimura M, Ohno S, Ando H, Katsuyama Y, Yamazaki M, Watanabe K, Goto K, Nakamura S, Bahram S, Inoko H: Triplet repeat polymorphism in the transmembrane region of the MICA gene: A strong association of six GCT repetitions with behcet disease. Proc Natl Acad Sci USA 1997; 94: 1298-1303
35. Johnson DR: Locus-specific constitutive and cytokine-induced HLA class I gene expression. J Immunol 2003; 170: 1894-1902
36. Salih HR, Rammensee HG, Steinle A: Cutting edge: Down-regulation of MICA on human tumors by proteolytic shedding. J Immunol 2002; 169: 4098-4102
37. Groh V, Wu J, Yee C, Spies T: Tumour-derived soluble MIC ligands impair expression of NKG2D and T cell activation. Nature 2002; 419: 734-738
38. Pober JS: Endothelial activation: Intracellular signaling pathways. Arthritis Res 2002; 4(suppl 3):S109-S116
39. Pober JS, Sessa WC: Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 2007; 7: 803-815
40. Fitau J, Boulday G, Coulon F, Quillard T, Charreau B: The adaptor molecule Lnk negatively regulates tumor necrosis factor-α-dependent VCAM-1 expression in endothelial cells through inhibition of the ERK1 and-2 pathways. J Biol Chem 2006; 281: 20148-20159
41. Lin D, Lavender H, Soilleux EJ, O'Callaghan CA: NF-κB regulates MICA gene transcription in endothelial cell through a genetically inhibitable control site. J Biol Chem 2012; 287: 4299-4310
42. Wu JD, Higgins LM, Steinle A, Cosman D, Haugk K, Plymate SR: Prevalent expression of the immunostimulatory MHC class I chainrelated molecule is counteracted by shedding in prostate cancer. J Clin Invest 2004; 114: 560-568
43. Cerboni C, Zingoni A, Cippitelli M, Piccoli M, Frati L, Santoni A: Antigen-Activated human T lymphocytes express cell surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK cell lysis. 2007; 110: 606-615
44. Nowbakht P, Ionescu MC, Rohner A, Kalberer CP, Rossy E, Mori L, Cosman D, De Libero G, Wodnar-Filipowicz A: Ligands for natural killer cell-Activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias. Blood 2005; 105: 3615-3622
45. Vivier E, Tomasello E, Paul P: Lymphocyte activation via NKG2D: Towards a new paradigm in immune recognitioñ Curr Opin Immunol 2002; 14: 306-311
46. Oppenheim DE, Roberts SJ, Clarke SL, Filler R, Lewis JM, Tigelaar RE, Girardi M, Hayday AC: Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat Immunol 2005; 6: 928-937
47. Tonnerre P, Gerard N, Chatelais M, Charreau B: MICA gene polymorphism in kidney allografts and possible impact of functionally relevant variants. Transplant Proc 2010; 42: 4318-4321
48. Suarez-Alvarez B, Lopez-Vazquez A, Diaz-Pena R, Diaz-Molina B, Blanco-Garcia RM, Alvarez-Lopez MR, Lopez-Larrea C: Posttransplant soluble MICA and MICA antibodies predict subsequent heart graft outcome. Transpl Immunol 2006; 17: 43-46
49. Zou Y, Mirbaha F, Stastny P: Contact inhibition causes strong downregulation of expression of MICA in human fibroblasts and decreased NK cell killing. Hum Immunol 2006; 67: 183-187
50. Molinero LL, Fuertes MB, Girart MV, Fainboim L, Rabinovich GA, Costas MA, Zwirner NW: NF-κB regulates expression of the MHC class I-related chain A gene in activated T lymphocytes. J Immunol 2004; 173: 5583-5590
51. Molinero LL, Fuertes MB, Fainboim L, Rabinovich GA, Zwirner NW: Up-regulated expression of MICA on activated T lymphocytes involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 map kinase, and calcineurin. J Leukoc Biol 2003; 73: 815-822
52. Xu X, Rao G, Gaffud MJ, Ding HG, Maki G, Klingemann HG, Groh V, Spies T, Caillat-Zucman S, Gattuso P, Plate J, Prinz RA: Clinicopathological significance of major histocompatibility complex class I-related chain A and B expression in thyroid cancer. J Clin Endocrinol Metab 2006; 91: 2704-2712